nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—Behcet's disease	0.969	1	CbGaD
Clenbuterol—TNF—Allograft Rejection—MICA—Behcet's disease	0.00196	0.0697	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—ITGB2—Behcet's disease	0.00153	0.0544	CbGpPWpGaD
Clenbuterol—TNF—IL27-mediated signaling events—STAT4—Behcet's disease	0.0013	0.0463	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—STAT4—Behcet's disease	0.000983	0.0349	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—IL10—Behcet's disease	0.000846	0.0301	CbGpPWpGaD
Clenbuterol—NGF—SHP2 signaling—NOS3—Behcet's disease	0.000777	0.0276	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—APOB—Behcet's disease	0.00076	0.027	CbGpPWpGaD
Clenbuterol—TNF—Amyotrophic lateral sclerosis (ALS)—CAT—Behcet's disease	0.000682	0.0242	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.000665	0.0236	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—STAT4—Behcet's disease	0.000619	0.022	CbGpPWpGaD
Clenbuterol—TNF—Overview of nanoparticle effects—CXCL8—Behcet's disease	0.000613	0.0218	CbGpPWpGaD
Clenbuterol—NGF—eye—Behcet's disease	0.000606	0.217	CbGeAlD
Clenbuterol—NGF—SIDS Susceptibility Pathways—IL10—Behcet's disease	0.000571	0.0203	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—ICAM1—Behcet's disease	0.000571	0.0203	CbGpPWpGaD
Clenbuterol—TNF—EBV LMP1 signaling—CXCL8—Behcet's disease	0.000526	0.0187	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—APOB—Behcet's disease	0.000523	0.0186	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—CTLA4—Behcet's disease	0.000461	0.0164	CbGpPWpGaD
Clenbuterol—CYP1A1—Oxidative Stress—CAT—Behcet's disease	0.000452	0.0161	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—CAT—Behcet's disease	0.000438	0.0156	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.000431	0.0153	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—APOB—Behcet's disease	0.000426	0.0151	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.000414	0.0147	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.000393	0.014	CbGpPWpGaD
Clenbuterol—NGF—spinal cord—Behcet's disease	0.000387	0.139	CbGeAlD
Clenbuterol—ADRB1—Endothelin Pathways—NOS3—Behcet's disease	0.000375	0.0133	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.000369	0.0131	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL10—Behcet's disease	0.000359	0.0127	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—CAT—Behcet's disease	0.000348	0.0124	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-B—Behcet's disease	0.000341	0.0121	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—APOB—Behcet's disease	0.000338	0.012	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—APOA1—Behcet's disease	0.000337	0.012	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.000329	0.0117	CbGpPWpGaD
Clenbuterol—NGF—nervous system—Behcet's disease	0.000326	0.117	CbGeAlD
Clenbuterol—CYP1A1—Tryptophan metabolism—CAT—Behcet's disease	0.000321	0.0114	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—ICAM1—Behcet's disease	0.00032	0.0114	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.000319	0.0113	CbGpPWpGaD
Clenbuterol—NGF—central nervous system—Behcet's disease	0.000314	0.113	CbGeAlD
Clenbuterol—TNF—TGF-beta Receptor Signaling—SERPINE1—Behcet's disease	0.000314	0.0112	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.000312	0.0111	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.000283	0.01	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCR1—Behcet's disease	0.000281	0.00998	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000268	0.00951	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—SERPINE1—Behcet's disease	0.000267	0.0095	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.000256	0.00908	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000254	0.00904	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.00025	0.00888	CbGpPWpGaD
Clenbuterol—NGF—brain—Behcet's disease	0.000249	0.0894	CbGeAlD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.000219	0.00778	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—TNF—Behcet's disease	0.000217	0.00773	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.000214	0.00761	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000212	0.00755	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL10—Behcet's disease	0.000208	0.0074	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TNF—Behcet's disease	0.000205	0.00729	CbGpPWpGaD
Clenbuterol—CYP1A2—Tryptophan metabolism—CAT—Behcet's disease	0.000205	0.00728	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—ICAM1—Behcet's disease	0.000201	0.00715	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—CXCL8—Behcet's disease	0.000196	0.00697	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR1—Behcet's disease	0.000167	0.00593	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR1—Behcet's disease	0.000165	0.00585	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR1—Behcet's disease	0.000163	0.0058	CbGpPWpGaD
Clenbuterol—CYP1A1—mouth—Behcet's disease	0.00016	0.0574	CbGeAlD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.00016	0.00568	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR1—Behcet's disease	0.000159	0.00564	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—SERPINE1—Behcet's disease	0.000155	0.00552	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR1—Behcet's disease	0.000144	0.00512	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CXCL8—Behcet's disease	0.000142	0.00506	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.000125	0.00443	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—APOA1—Behcet's disease	0.000123	0.00437	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—Behcet's disease	0.00012	0.00427	CbGpPWpGaD
Clenbuterol—ADRB1—cardiac atrium—Behcet's disease	0.00012	0.043	CbGeAlD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000115	0.0041	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000115	0.0041	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.000114	0.00404	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR1—Behcet's disease	9.42e-05	0.00335	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	9.26e-05	0.00329	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR1—Behcet's disease	9.22e-05	0.00328	CbGpPWpGaD
Clenbuterol—CYP1A1—skin of body—Behcet's disease	8.85e-05	0.0317	CbGeAlD
Clenbuterol—ADRB1—Signaling by GPCR—CCR1—Behcet's disease	8.56e-05	0.00304	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR1—Behcet's disease	8.52e-05	0.00303	CbGpPWpGaD
Clenbuterol—ADRB1—nervous system—Behcet's disease	8.49e-05	0.0304	CbGeAlD
Clenbuterol—ADRB2—Signaling by GPCR—CCR1—Behcet's disease	8.37e-05	0.00297	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—Behcet's disease	8.28e-05	0.00294	CbGpPWpGaD
Clenbuterol—ADRB1—central nervous system—Behcet's disease	8.18e-05	0.0293	CbGeAlD
Clenbuterol—CYP1A1—mammalian vulva—Behcet's disease	8.07e-05	0.0289	CbGeAlD
Clenbuterol—NGF—Signaling Pathways—APOB—Behcet's disease	7.77e-05	0.00276	CbGpPWpGaD
Clenbuterol—CYP1A1—cardiac atrium—Behcet's disease	7.73e-05	0.0277	CbGeAlD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	7.36e-05	0.00262	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	7.36e-05	0.00262	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL8—Behcet's disease	7.05e-05	0.00251	CbGpPWpGaD
Clenbuterol—ADRB1—brain—Behcet's disease	6.49e-05	0.0233	CbGeAlD
Clenbuterol—NGF—Signaling Pathways—APOA1—Behcet's disease	6.15e-05	0.00218	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	5.5e-05	0.00195	CbGpPWpGaD
Clenbuterol—CYP1A1—nervous system—Behcet's disease	5.48e-05	0.0196	CbGeAlD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	5.38e-05	0.00191	CbGpPWpGaD
Clenbuterol—CYP1A1—central nervous system—Behcet's disease	5.27e-05	0.0189	CbGeAlD
Clenbuterol—ADRB1—Signaling Pathways—CCR1—Behcet's disease	5.05e-05	0.0018	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR1—Behcet's disease	4.94e-05	0.00176	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SERPINE1—Behcet's disease	4.88e-05	0.00173	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NOS3—Behcet's disease	4.66e-05	0.00166	CbGpPWpGaD
Clenbuterol—CYP1A1—brain—Behcet's disease	4.19e-05	0.015	CbGeAlD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL8—Behcet's disease	4.19e-05	0.00149	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.17e-05	0.00148	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—Behcet's disease	4.13e-05	0.00147	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—Behcet's disease	4.09e-05	0.00146	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOB—Behcet's disease	4.02e-05	0.00143	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—Behcet's disease	3.99e-05	0.00142	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—Behcet's disease	3.62e-05	0.00129	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.3e-05	0.00117	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOA1—Behcet's disease	3.18e-05	0.00113	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	2.66e-05	0.000945	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SERPINE1—Behcet's disease	2.52e-05	0.000897	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOS3—Behcet's disease	2.41e-05	0.000857	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOB—Behcet's disease	2.39e-05	0.000848	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—Behcet's disease	2.37e-05	0.000841	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOB—Behcet's disease	2.33e-05	0.000829	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—Behcet's disease	2.31e-05	0.000822	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—Behcet's disease	2.15e-05	0.000763	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—Behcet's disease	2.14e-05	0.00076	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.1e-05	0.000748	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—Behcet's disease	2.1e-05	0.000747	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAT—Behcet's disease	1.91e-05	0.00068	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOA1—Behcet's disease	1.89e-05	0.000671	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOB—Behcet's disease	1.86e-05	0.00066	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOA1—Behcet's disease	1.85e-05	0.000656	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—Behcet's disease	1.5e-05	0.000533	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOA1—Behcet's disease	1.47e-05	0.000522	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—Behcet's disease	1.47e-05	0.000521	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOS3—Behcet's disease	1.43e-05	0.000508	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOS3—Behcet's disease	1.4e-05	0.000497	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—Behcet's disease	1.27e-05	0.000451	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—Behcet's disease	1.24e-05	0.000441	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAT—Behcet's disease	1.22e-05	0.000433	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOB—Behcet's disease	1.18e-05	0.000421	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NOS3—Behcet's disease	1.11e-05	0.000396	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA1—Behcet's disease	9.37e-06	0.000333	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NOS3—Behcet's disease	7.1e-06	0.000252	CbGpPWpGaD
